{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:14:08Z","timestamp":1789776848045,"version":"4.0.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.annder.2023.05.004","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T15:34:23Z","timestamp":1692200063000},"page":"199-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Treatment of pediatric ocular rosacea: A systematic review"],"prefix":"10.1016","volume":"150","author":[{"given":"S.","family":"Khaslavsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5166-1883","authenticated-orcid":false,"given":"S.Y.","family":"Starkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Avraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0834-3783","authenticated-orcid":false,"given":"N.","family":"Kashetsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1058-9413","authenticated-orcid":false,"given":"I.","family":"Mukovozov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2023.05.004_b0005","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jaad.2017.08.037","article-title":"Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee","volume":"78","author":"Gallo","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2023.05.004_b0010","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.survophthal.2017.07.005","article-title":"Treatment of ocular rosacea","volume":"63","author":"Wladis","year":"2018","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.annder.2023.05.004_b0015","first-page":"544","article-title":"Treatment of ocular rosacea: comparative study of topical cyclosporine and oral doxycycline","volume":"8","author":"Arman","year":"2015","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.annder.2023.05.004_b0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/archdermatol.2007.50","article-title":"Cutaneous and ocular signs of childhood rosacea","volume":"144","author":"Chamaillard","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2023.05.004_b0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/09273948.2019.1668951","article-title":"Pediatric ocular acne rosacea: clinical features and long term follow-up of sixteen cases","volume":"29","author":"Donmez","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.annder.2023.05.004_b0030","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0002-9394(03)00890-0","article-title":"Ocular rosacea in childhood","volume":"137","author":"Nazir","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.annder.2023.05.004_b0035","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.ajo.2006.06.047","article-title":"Pediatric ocular acne rosacea: long-term treatment with systemic antibiotics","volume":"142","author":"Cetinkaya","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.annder.2023.05.004_b0040","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/bjd.20485","article-title":"British Association of Dermatologists guidelines for the management of people with rosacea 2021","volume":"185","author":"Hampton","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2023.05.004_b0045","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.annder.2023.05.004_b0050","unstructured":"OCEBM Levels of Evidence Working Group. The Oxford 2011 Levels of Evidence. Centre for Evidence-Based Medicine. Accessed April 3, 2022. https:\/\/www.cebm.net\/wp-content\/uploads\/2014\/06\/CEBM-Levels-of-Evidence-2.1.pdf."},{"key":"10.1016\/j.annder.2023.05.004_b0055","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1869-5760-3-38","article-title":"Efficacy of azithromycin 1.5% eye drops in childhood ocular rosacea with phlyctenular blepharokeratoconjunctivitis","volume":"3","author":"Doan","year":"2013","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.annder.2023.05.004_b0060","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/ICO.0b013e31802e3a54","article-title":"Evaluation and treatment of children with ocular rosacea","volume":"26","author":"Donaldson","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.annder.2023.05.004_b0065","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1001\/archopht.1993.01090020082028","article-title":"Acne rosacea with keratitis in childhood","volume":"111","author":"Erzurum","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.annder.2023.05.004_b0070","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/jdv.14402","article-title":"Systemic therapy of ocular and cutaneous rosacea in children","volume":"31","author":"Gonser","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2023.05.004_b0075","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1440-0960.2009.00557.x","article-title":"Childhood ocular rosacea: considerations for diagnosis and treatment","volume":"50","author":"Hong","year":"2009","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.annder.2023.05.004_b0080","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jfo.2011.07.008","article-title":"Metronidazole: alternative treatment for ocular and cutaneous rosacea in the pediatric population","volume":"34","author":"L\u00e9oni","year":"2011","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.annder.2023.05.004_b0085","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00347-020-01279-z","article-title":"Pediatric ocular rosacea effectively treated with topical 1.5% azithromycin eye drops","volume":"118","author":"Starosta","year":"2021","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.annder.2023.05.004_b0090","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.jaad.2013.04.042","article-title":"Ocular rosacea: common and commonly missed","volume":"69","author":"Vieira","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2023.05.004_b0095","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/01.icu.0000143683.14738.76","article-title":"Ocular rosacea: an update on pathogenesis and therapy","volume":"15","author":"Stone","year":"2004","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.annder.2023.05.004_b0100","unstructured":"Committee on Infectious Diseases, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH. Tetracyclines. In: American Academy of Pediatrics, editors, Red Book: 2021\u20132024 Report of the Committee on Infectious Diseases 2021 32nd ed. 2021. https:\/\/doi.org\/10.1542\/9781610025782-S4_001_003."},{"key":"10.1016\/j.annder.2023.05.004_b0105","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1001\/archopht.123.12.1667","article-title":"Blepharokeratoconjunctivitis in children","volume":"123","author":"Hammersmith","year":"2005","journal-title":"Arch Ophthalmol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963823000467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963823000467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:11:33Z","timestamp":1758971493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963823000467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0151963823000467"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2023.05.004","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of pediatric ocular rosacea: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2023.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}